Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We recently welcomed our Scientific Advisory Board (SAB) and the Kennedy Trust Scientific Review Board (TSRB) to the Institute to review our current activities and future plans.

SAB poster demonstrations
Members of the SAB and TSRB review research posters

Meeting for the first time in person since the COVID-19 pandemic, Professor Dame Fiona Powrie, Director of the Kennedy Institute said: “We are very excited to see the members of the SAB and TSRB at the Kennedy after such a long break. We are delighted to have the opportunity to present our world class research and cutting edge technology platforms as well as showcase our training programmes for  students and post doctoral fellows alongside a new governance structure that will enable us to be nimble and responsive to the needs of our research groups. We are particularly proud to host the Board’s in  our new roof extension which forms part of our strategy to strengthen data science approaches alongside our lab-based research.”

The SAB is  an independent external advisory board comprised of eminent scientists from across the globe in research fields relevant to the work of the Kennedy. Over two days the board reviewed  the Institute’s science platforms, its career development policies and DPhil teaching programme giving strong endorsement of the work of the Institute and its research culture.

The Trust Scientific Review Board (TSRB) convened by the Kennedy Trust is an independent panel to review the activities the fund as required by their charitable status. Commenting on the visit, Kennedy Trust’s CEO, Dr Stephen Simpson said: “This review by independent world-class scientists who gave their valuable time, is itself a testament to the international standing of the Kennedy Institute. The presentations and discussions over the two days were engaging and detailed and will form an important part of the forthcoming TSRB report, which is central to the thorough periodic review the Trust undertakes of its investment.”

Similar stories

The Kennedy Institute launches its single cell facility

We spoke to Irina Udalova and Stephen Sansom about the Kennedy’s new single cell facility and how it will enhance research at the Institute and beyond.

Professor Michael Dustin appointed new Chair in Molecular Immunology

A generous gift from the Kennedy Trust for Rheumatology Research has enabled the creation of a new Chair in Molecular Immunology at the University of Oxford.

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Mathematician boosts data science research at the Kennedy Institute

Welcome to Yang Luo who has joined the Kennedy Institute as the Principal Investigator of the Luo Group. Her lab is leading the investigation into how genetic variations contribute to diseases of the immune system.

NIHR funding for musculoskeletal and inflammatory disease research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients.

Leducq Foundation grant boosts cardiovascular research

The Leducq Foundation has awarded $7.5 million to researchers at the University of Oxford and their collaborators to advance immunotherapy as a treatment for cardiovascular disease, the leading cause of death in the UK.